Name: Public Meeting on the Reauthorization of the Biosimilar User Fee Act (BsUFA)
Start: 2026-10-26
End: 2026-10-26

Regulatory and quality

About

This meeting addresses the reauthorization process for the Biosimilar User Fee Act.

Listed from Center for Drug Evaluation and Research